1. Home
  2. AXR vs STIM Comparison

AXR vs STIM Comparison

Compare AXR & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$25.53

Market Cap

136.8M

Sector

Real Estate

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.29

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
STIM
Founded
1961
2003
Country
United States
United States
Employees
49
N/A
Industry
Homebuilding
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.8M
140.6M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
AXR
STIM
Price
$25.53
$1.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$30.00
$3.00
AVG Volume (30 Days)
12.6K
2.6M
Earning Date
03-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
89.60
57.25
EPS
1.68
N/A
Revenue
$12,831,000.00
$52,776,000.00
Revenue This Year
$10.12
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
$15.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$0.80
52 Week High
$29.01
$4.84

Technical Indicators

Market Signals
Indicator
AXR
STIM
Relative Strength Index (RSI) 45.23 44.32
Support Level $23.76 $1.21
Resistance Level $28.68 $1.75
Average True Range (ATR) 1.33 0.14
MACD 0.01 0.01
Stochastic Oscillator 27.45 29.60

Price Performance

Historical Comparison
AXR
STIM

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: